Combined hormonal contraception: what users know about its risks and its benefits
DOI:
https://doi.org/10.32385/rpmgf.v39i3.13454Keywords:
Hormonal contraception, Contraception, Knowledge, Risks and benefits, Health literacyAbstract
Introduction: It is estimated that, in Portugal, 94% of women use some contraceptive method. Combined hormonal contraception has been the preferred choice for most women. These contraceptive methods have several health benefits in addition to contraception, but they also carry some risks. Thus, it is of interest to assess whether the users are aware of them.
Methods: Through the application of a questionnaire to 150 users of combined hormonal contraception aged between 18 and 50 years, being followed in consultations at primary health care units in Cova da Beira, the aim was to assess the literacy about the benefits and risks of their combined hormonal contraceptive method.
Results: In the total of 13 questions about the benefits and risks of combined hormonal contraception, eight of them presented a percentage of women who admitted not knowing the answer greater than 50%. The most correctly answered question by women was related to the menstrual cycles, the most wrongly answered was related to headaches, and the one where women more often admitted not knowing the answer was the one about endometrial cancer. Of the total sample, 142 women indicated the doctor/nurse’s recommendation as the main reason for choosing the contraceptive method.
Discussion: The high degree of ignorance of the benefits and risks of the contraceptive method may be due to insufficient provision of information by health professionals and/or lack of interest on the part of users.
Conclusion: Users of combined hormonal contraception are not fully informed about the benefits and risks inherent to its use. In this way, it is necessary to find interventions that improve women’s literacy in relation to their contraceptive medication.
Downloads
References
Águas F, Bombas T, Silva DP. Avaliação das práticas contracetivas das mulheres em Portugal [Evaluation on Portuguese women contraceptive practice]. Acta Obstet Ginecol Port. 2016;10(3):184-92. Portuguese
Sociedade Portuguesa da Contraceção. Consenso sobre contraceção 2020 [Internet]. SPDC; 2020. Available from: https://www.spdc.pt/images/CONSENSOS_FINAL.pdf
Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab. 2013;27(1):3-12.
Book of Abstracts: the 15th Congress of the European Society of Contraception and Reproductive Health. Eur J Contracept Reprod Health Care. 2018;23(Suppl 1):1-143.
Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol. 2017;216(6):580.e1-9.
Casanova R, Chuang A, Goepfert AR, Hueppchen NA, Weiss PM, Beckman CR, et al. Beckmann and Ling’s obstetrics and gynecology. 8th ed. Wolters Kluwer; 2019. ISBN 9781496353092
Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377(23):2228-39.
Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015;2015(8):CD011054.
Ebrahimi H, Amanpour F, Haghighi NB. Prevalence and risk factors of varicose veins among female hairdressers: a cross sectional study in north-east of Iran. J Res Health Sci. 2015;15(2):119-23.
Scheuringer A, Lundin C, Derntl B, Pletzer B, Poromaa IS. Use of an estradiol-based combined oral contraceptives has no influence on attentional bias or depressive symptoms in healthy women. Psychoneuroendocrinology. 2020;113:104544.
Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reprod Med. 2018;3:9.
Philipson S, Wakefield CE, Kasparian NA. Women’s knowledge, beliefs, and information needs in relation to the risks and benefits associated with use of the oral contraceptive pill. J Womens Health. 2011;20(4):635-42.
Nappi RE, Pellegrinelli A, Campolo F, Lanzo G, Santamaria V, Suragna A, et al. Effects of combined hormonal contraception on health and wellbeing: women’s knowledge in northern Italy. Eur J Contracept Reprod Health Care. 2015;20(1):36-46.
Machado RB, Melo NR, Prota FE, Lopes GP, Megale A. Women’s knowledge of health effects of oral contraceptives in five Brazilian cities. Contraception. 2012;86(6):698-703.
Vogt C, Schaefer M. Disparities in knowledge and interest about benefits and risks of combined oral contraceptives. Eur J Contracept Reprod Health Care. 2011;16(3):183-93.
Esteves AF. Noções e dinâmica da utilização dos contraceptivos orais [dissertation]. Covilhã: Universidade da Beira Interior; 2011.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
